Let's talk about it: The controversy surrounding menstrual leave policy.
This paper explores the controversy surrounding menstrual leave policies, though specific findings regarding endometriosis or adenomyosis are not provided in the available text.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This letter discusses the controversy and public health implications of implementing menstrual leave policies, particularly within the context of India’s current lack of a comprehensive national framework. It highlights that while conditions like endometriosis and adenomyosis cause severe symptoms affecting workforce participation, critics argue such policies might reinforce gender stereotypes or lead to discrimination without proper guidelines. The authors contend that acknowledging these gender-specific health requirements is crucial for advancing gender equality and reducing social taboos surrounding menstruation. Relevance to endometriosis: listed as one indication for menstrual leave, though the paper's main focus is workplace policy rather than clinical management.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
3,830 characters
· extracted from
oa-html
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-10-04T09:26:46.659050+00:00
- unpaywall
- last seen: 2026-05-21T05:10:58.409756+00:00